Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Effectiveness of Biodentine® in Pulpotomies Primary Teeth Clinical Trial

Official title:

Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01655342
• Other study ID #: Moran- HMO-CTIL
• Status: Completed
• Start date: August 2012
• Est. completion date: December 1, 2018

Study information

• Verified date: February 2020
• Source: Hadassah Medical Organization
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Clinical and radiographic assessment of Biodentine® as a pulp dressing material for pulpotomy treatment in human primary molars.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 58
• Est. completion date: December 1, 2018
• Est. primary completion date: December 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 3 Years to 12 Years

Eligibility

Inclusion Criteria:

• one or more primary teeth which requires pulpotomy.

Exclusion Criteria:

• not healthy patients,

• patients with teeth which requires pulpectomy.

Related Conditions & MeSH terms

• Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Locations

Country	Name	City	State
Israel	Hadassah Medical Organization	Jerusalem

Sponsors (1)

Lead Sponsor	Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Laurent P, Camps J, About I. Biodentine(TM) induces TGF-ß1 release from human pulp cells and early dental pulp mineralization. Int Endod J. 2012 May;45(5):439-48. doi: 10.1111/j.1365-2591.2011.01995.x. Epub 2011 Dec 22. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success of the primary molar pulpotomy		One year